Alison Snyder
Managing Editor at Axios
Writer at Axios Science Newsletter
Author of Axios Science newsletter; Managing editor @Axios. [email protected].
Articles
-
1 week ago |
axios.com | Tina Reed |Alison Snyder
Illustration: Lindsey Bailey/AxiosThe Food and Drug Administration's decision to phase out animal testing in drug development is being hailed as a potential game changer, even though proponents say it may take years to get to a point where alternative methods can be used for all applications. Why it matters: Pharmaceutical companies and biotechs say other methods could accelerate the process for bringing cures to market and give them more flexibility and predictability.
-
1 week ago |
axios.com | Alison Snyder
-
2 weeks ago |
axios.com | Maya Goldman |Alison Snyder
Health Secretary Robert F. Kennedy Jr.'s stated goal of ending what he calls a chronic disease epidemic is in conflict with some of the Trump administration's early regulatory rollbacks and DOGE-directed cuts, experts tell Axios. Why it matters: Some 129 million Americans suffer from diabetes, hypertension, arthritis and other chronic diseases, with tens of millions more expected to develop chronic illness in the next five years. A disproportionate number are low-income or otherwise disadvantaged.
-
3 weeks ago |
axios.com | Maya Goldman |Eleanor Hawkins |Alison Snyder
Mass layoffs at the Department of Health and Human Services are leaving a communications gulf within the federal health system that millions of Americans rely on for information about drug safety, product recalls, disease outbreaks and other public health threats. Why it matters: HHS Secretary Robert F. Kennedy Jr. frequently says he's bringing "radical transparency" to the agency.
-
3 weeks ago |
axios.com | Erica Pandey |Alison Snyder
The U.S. is freezing research funding, canceling projects, firing thousands of federal scientists and creating an atmosphere of uncertainty that scientists warn could slam the brakes on progress. Why it matters: America has enjoyed decades of dominance in science and technology — plus the economic boom, medical advancements and global influence that come with it.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 1K
- DMs Open
- No
RT @BrandonSorbom: Tomorrow @SOSV Climate Tech Summit, @axios' @alisonmsnyder and I will discuss an age-old question: when we say fusion is…
RT @sarahookr: If you made it this far, read the excellent article by @alisonmsnyder for @axios covering these different perspectives on wh…
Huge congrats to @BarakRavid! He's given us a critical view into some of the most consequential discussions and debates for the world right now. And he's only been in DC for seven months -- can't wait to see what he uncovers next.
Congratulations to @BarakRavid, winner of the 2024 WHCA Aldo Beckman Award for Overall Excellence in White House Coverage. To see the winning coverage and more, https://t.co/MN9nCoq7vw